SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending after announcing a non-exclusive license agreement with Pfizer for its Matrix-M adjuvant, providing significant validation for the technology. This deal, building on previous collaborations, is driving community excitement and fueling discussions about the adjuvant's potential applications and the company's future partnerships amidst notable short interest.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is driving significant conversation as escalating US-EU trade tensions, particularly over Greenland and proposed tariffs, spark widespread market uncertainty and a risk-off shift. The community is sharply divided, with intense debate over whether current volatility signals a deeper correction or presents a key buying opportunity amidst ongoing institutional interest and broader macroeconomic shifts.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is generating significant buzz following positive regulatory advancements for its ANKTIVA therapy, with the FDA outlining a path to resubmission for papillary bladder cancer that requires no new clinical trials. This news, combined with recent international approvals, is fueling strong community sentiment around the potential for a "cancer cure" and intense discussions anticipating a substantial short squeeze.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is currently a major talking point among investors, primarily driven by its upcoming earnings report and the proposed all-cash acquisition of Warner Bros. Discovery assets, which has sparked a debate over potential growth versus debt concerns. The community is closely watching for strong ad-tier performance and subscriber metrics, particularly after a previous tax-related earnings miss, with sentiment split on whether recent oversold conditions signal a significant rebound or continued volatility.

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPY is trending as market participants react to heightened geopolitical tensions, specifically former President Trump's recent tariff threats against NATO allies over Greenland and an anticipated Supreme Court ruling on presidential tariff authority. This has sparked a fierce debate among investors, with some advocating to "buy the dip" and anticipating a rapid "Taco Trade" rebound, while others warn of a significant market correction. Adding to the volatility are concerns surrounding Japan's bond market instability, creating a complex and uncertain trading environment.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

BOIL is currently experiencing a significant surge, fueled by an intense Arctic air invasion across the United States that is driving up natural gas demand and futures prices. The strong upward momentum has triggered a notable short squeeze, with the community actively discussing substantial profits and anticipating continued upside as extreme cold weather is projected to persist. This volatility is characteristic of the 2x leveraged ETF, attracting both profit-takers and those eyeing further gains.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is experiencing significant volatility amid escalating geopolitical tensions, notably the US asserting control over Venezuela's oil and ongoing debates surrounding US tariffs, fueling a "flight to quality" narrative for some. The community is actively discussing whether these events, alongside large institutional bond purchases, will continue to boost Treasuries as a safe haven or intensify concerns over US debt and the Federal Reserve's independence.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin ($APP) is experiencing significant volatility and a notable price decline following a new short report alleging the company's involvement in money laundering. This report has sparked intense debate among investors, with many attributing the drop to market manipulation and viewing it as a buying opportunity, while others express concern over the serious accusations despite recent bullish analyst upgrades.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is trending due to overwhelmingly positive data from its Phase 1 clinical trial of soquelitinib for atopic dermatitis, with community discussions highlighting its strong efficacy in treatment-resistant patients. Investors are actively debating the potential for this novel oral ITK inhibitor to disrupt the significant atopic dermatitis market, fueling speculation of future partnerships or an acquisition and validating its broader immune-modulating platform.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares ETF (GLD) is trending strongly as renewed geopolitical tensions, including recent tariff threats concerning European countries over Greenland, fuel a broad flight to safety. The community views gold as a crucial hedge against eroding fiat currency confidence and economic instability, driving prices to consistent new highs. Many are discussing significant further appreciation as these global uncertainties persist.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$VMI &quot;Heads up alert! Upcoming earnings on Tuesday, 10/21/2025 for $VMI 
Bullish (8.3) 
 
--- 
Financial Analysis: 
Valmont Industries (VMI) has exhibited strong growth and solid fundamentals, as evidenced by its recent performance metrics and market activities. 
The company&#39;s stock has consistently reached new highs, with a remarkable 31.42% return over the past year, and a recent peak at $384.84. 
Valmont&#39;s P/E ratio is competitive within the industry, reflecting robust earnings potential relative to its share price. 
The company&#39;s earnings per share (EPS) have shown consistent growth, underpinning investor confidence and justifying recent upgrades to a &quot;&quot;Buy&quot;&quot; rating by analysts such as Zacks, who now rate it as a #2 (Buy). 
Revenue forecasts for Valmont remain positive, driven by its diversified portfolio in infrastructure and agricultural productivity solutions. 
Compared to its peers in the building materials sector, Valmont stands out with a strong momentum, bolstered by strategic initiatives and sustained demand for its offerings. 
Additionally, the company&#39;s stock has gained traction among institutional investors, as evidenced by its inclusion in lists advocating for diversified stock investments. 
 
Upcoming Earnings Reports: 
Valmont Industries is scheduled to release its third-quarter 2025 financial results on October 21, 2025. 
Analysts have high expectations for this release, anticipating continued growth in revenue and EPS, driven by the company&#39;s strategic focus and market position. 
Historically, Valmont has demonstrated a pattern of meeting or exceeding earnings expectations, which has contributed to its positive market sentiment and share price momentum. 
Analyst consensus estimates suggest that Valmont will maintain its earnings growth trajectory, leveraging its competitive advantages in infrastructure and agriculture sectors. 
The upcoming earnings report is pivotal, as it will provide insights into the company&#39;s operational efficiency and ability to sustain its growth momentum. 
Any positive surprises in the earnings announcement could further catalyze the stock&#39;s upward movement, while any shortfall could trigger a reevaluation of its current valuation. 
 
Sector Performance: 
The building materials sector, to which Valmont belongs, has experienced a mixed performance in recent quarters. 
However, infrastructure spending and agricultural productivity advancements have provided a favorable backdrop for companies like Valmont. 
The sector benefits from increased government investments in infrastructure and a growing emphasis on sustainable and efficient agricultural practices. 
While some peers have struggled with supply chain disruptions and cost pressures, Valmont&#39;s strategic positioning and diversified offerings have allowed it to outperform many of its competitors. 
The sector&#39;s outlook remains promising, with potential tailwinds from policy support and technological advancements, positioning Valmont well for continued success. 
 
- Funds were net buyers of $VMI during the previous reporting quarter. 
 
- Funds with large holdings in $VMI include: 
 
- Ensign Peak Advisors, MV: $4MM. Fund Rank: 67% 
 
- Last 10 days performance: 4% 
- Last 30 days performance: 9% 
- Last 90 days performance: 22% 
 
Some of the latest news articles: 
 - Title: Valmont Industries (VMI) Earnings Expected to Grow: What to Know Ahead of Next Week&#39;s Release 
Publication Date: 10/14/2025 2:00:07 PM, Source: yahoo 
URL: https://finance.yahoo.com/news/valmont-industries-vmi-earnings-expected-140007173.html?.tsrc=rss 
 
 - Title: 2 Unpopular Stocks That Deserve Some Love and 1 We Brush Off 
Publication Date: 10/14/2025 4:42:15 AM, Source: yahoo 
URL: https://finance.yahoo.com/news/2-unpopular-stocks-deserve-love-044215321.html?.tsrc=rss 
 
 - Title: Valmont Industries (VMI): Evaluating Valuation as Shares Rise 6% Over the Past Month 
Publication Date: 10/7/2025 2:05:24 PM, Source: yahoo 
URL: https://finance.yahoo.com/news/valmont-industries-vmi-evaluating-valuation-140524229.html?.tsrc=rss 
 
 - Title: Implied Volatility Surging for Valmont Industries Stock Options 
Publication Date: 10/6/2025 4:19:00 PM, Source: yahoo 
URL: https://finance.yahoo.com/news/implied-volatility-surging-valmont-industries-161900278.html?.tsrc=rss 
 
Follow us on stocktwits.com for more earnings alerts. Not a financial advice. Not a trading signal.&quot;

Valmont (VMI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo Finance

Valmont Industries (VMI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.

2 Unpopular Stocks That Deserve Some Love and 1 We Brush Off

Valmont Industries (VMI) shares continued their steady climb this month, rising about 6% over the past month and more than 17% in the past 3 months. Investors are looking closely at what is driving the stock's momentum. See our latest analysis for Valmont Industries.

Valmont Industries (VMI): Evaluating Valuation as Shares Rise 6% Over the Past Month

Investors need to pay close attention to VMI stock based on the movements in the options market lately.

Implied Volatility Surging for Valmont Industries Stock Options

Stocktwits provides real-time stock, crypto & international market data to keep you up-to-date. Find top news headlines, discover your next trade idea, share & gain insights from traders and investors from around the world, build a watchlist, buy US stocks, & create and manage your portfolio.

Stocktwits

Stocktwits - Stock Market Live Quotes, Social Community Discussions, News, Stock Rankings & Earnings

StockTwits Web

Valmont Industries, Inc.

 "Heads up alert! Upcoming earnings on Tuesday, 10/21/2025 for 

 
Bullish (8.3) 
 
--- 
Financial Analysis: 
Valmont Industries (VMI) has exhibited strong growth and solid fundamentals, as evidenced by its recent performance metrics and market activities. 
The company's stock has consistently reached new highs, with a remarkable 31.42% return over the past year, and a recent peak at $384.84. 
Valmont's P/E ratio is competitive within the industry, reflecting robust earnings potential relative to its share price. 
The company's earnings per share (EPS) have shown consistent growth, underpinning investor confidence and justifying recent upgrades to a ""Buy"" rating by analysts such as Zacks, who now rate it as a #2 (Buy). 
Revenue forecasts for Valmont remain positive, driven by its diversified portfolio in infrastructure and agricultural productivity solutions. 
Compared to its peers in the building materials sector, Valmont stands out with a strong momentum, bolstered by strategic initiatives and sustained demand for its offerings. 
Additionally, the company's stock has gained traction among institutional investors, as evidenced by its inclusion in lists advocating for diversified stock investments. 
 
Upcoming Earnings Reports: 
Valmont Industries is scheduled to release its third-quarter 2025 financial results on October 21, 2025. 
Analysts have high expectations for this release, anticipating continued growth in revenue and EPS, driven by the company's strategic focus and market position. 
Historically, Valmont has demonstrated a pattern of meeting or exceeding earnings expectations, which has contributed to its positive market sentiment and share price momentum. 
Analyst consensus estimates suggest that Valmont will maintain its earnings growth trajectory, leveraging its competitive advantages in infrastructure and agriculture sectors. 
The upcoming earnings report is pivotal, as it will provide insights into the company's operational efficiency and ability to sustain its growth momentum. 
Any positive surprises in the earnings announcement could further catalyze the stock's upward movement, while any shortfall could trigger a reevaluation of its current valuation. 
 
Sector Performance: 
The building materials sector, to which Valmont belongs, has experienced a mixed performance in recent quarters. 
However, infrastructure spending and agricultural productivity advancements have provided a favorable backdrop for companies like Valmont. 
The sector benefits from increased government investments in infrastructure and a growing emphasis on sustainable and efficient agricultural practices. 
While some peers have struggled with supply chain disruptions and cost pressures, Valmont's strategic positioning and diversified offerings have allowed it to outperform many of its competitors. 
The sector's outlook remains promising, with potential tailwinds from policy support and technological advancements, positioning Valmont well for continued success. 
 
- Funds were net buyers of 

 during the previous reporting quarter. 
 
- Funds with large holdings in 

 include: 
 
- Ensign Peak Advisors, MV: $4MM. Fund Rank: 67% 
 
- Last 10 days performance: 4% 
- Last 30 days performance: 9% 
- Last 90 days performance: 22% 
 
Some of the latest news articles: 
 - Title: Valmont Industries (VMI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release 
Publication Date: 10/14/2025 2:00:07 PM, Source: yahoo 
URL: 

 
 
 - Title: 2 Unpopular Stocks That Deserve Some Love and 1 We Brush Off 
Publication Date: 10/14/2025 4:42:15 AM, Source: yahoo 
URL: 

 
 
 - Title: Valmont Industries (VMI): Evaluating Valuation as Shares Rise 6% Over the Past Month 
Publication Date: 10/7/2025 2:05:24 PM, Source: yahoo 
URL: 

 
 
 - Title: Implied Volatility Surging for Valmont Industries Stock Options 
Publication Date: 10/6/2025 4:19:00 PM, Source: yahoo 
URL: 